Meeting SWAG Board Title Implementation of a Timed OGD Pathway Agenda Item 12 Date 23/08/2019 Author Emma Derrick Summary The SWAG Cancer Alliance have been asked to report on the progress towards implementing the oesophago-gastric pathway in all Trusts. Cancer Alliances are to work with the system to support providers to implement the best practice timed pathway by 1 April 2020. The evidence base for this is that faster pathways can help to ease patient anxiety and, at best, for those diagnosed with cancer, can lead to quicker treatment, a lower risk of complications, an enhanced patient experience and improved cancer outcomes. Recommendation: Outstanding returns from YDH, SFT, NBT, Weston, RUH, Glos
Transcript
Meeting SWAG BoardTitle Implementation of a Timed OGD PathwayAgenda Item 12 Date 23/08/2019Author Emma DerrickSummary
The SWAG Cancer Alliance have been asked to report on the progress towards implementing the oesophago-gastric pathway in all Trusts.
Cancer Alliances are to work with the system to support providers to implement the best practice timed pathway by 1 April 2020.
The evidence base for this is that faster pathways can help to ease patient anxiety and, at best, for those diagnosed with cancer, can lead to quicker treatment, a lower risk of complications, an enhanced patient experience and improved cancer outcomes.
Recommendation: Outstanding returns from YDH, SFT, NBT, Weston, RUH, Glos
Information & Background
The NHS England Early Diagnosis Cancer Team published the following documents in April 2019. They are available at https://www.england.nhs.uk/cancer/resources.
1. National Cancer Waiting Times Monitoring Dataset Guidance v10.02. Implementing a timed oesophago-gastric cancer timed pathway3. Test site top tips – Learning from Faster Diagnosis Standard test sites
For information:
The Cancer Waiting Times Guidance v10.0 is also available from NHS Digital’s cancer waits page: https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-collections/cancerwaitingtimescwt.
The oesophago-gastric cancer pathway handbook will support the system to deliver part of the NHS Planning Guidance 2019/20 (see s2.2.4 in Annex B which sets out a requirement for cancer alliances to lead on local implementation – https://www.england.nhs.uk/operational-planning-and-contracting/).
The oesophago-gastric cancer pathway is also referenced in the Cancer Waiting Times Guidance v10.0 (see section s2.6.2 on how to ‘start the clock’ for this pathway in regards to the new Faster Diagnosis Standard).
Therefore for pathways that are GP Direct Access OGD – triage to been seen in OPA – OPA. Start a 2ww referral at data of triage. OPA will be 2ww clock stop. The “triage” is likely to be decision on day of OGD itself.
Cancer Alliances Reporting Requirements:
SWAG Cancer Alliance have been asked to report on the progress towards implementing the oesophago-gastric pathway in all Trusts.
‘Implementing A Timed Oesophago Gastric Cancer Pathway’:
The supporting ‘Data Definitions’ document outlines:
Purpose (rationale) Cancer Alliances are to work with the system to support providers to implement the best practice timed pathway by 1 April 2020
Evidence and policy base Faster pathways can help to ease patient anxiety and, at best, for those diagnosed with cancer, can lead to quicker treatment, a lower risk of complications, an enhanced patient experience and improved cancer outcomes.
The Cancer Alliances are required to report on a set of specific deliverables, these being:
Timed pathway for oesophago-gastric (OG) cancer
% % of Trusts that have performed a gap analysis on implementation of the 5 pathway steps (expected by Q1)
% % of Trusts that have a trajectory and plan agreed to implement the 5 pathway steps (expected by Q2)
% % of Trusts that have implemented the 5 pathway steps (Q3)% % of Trusts that have implemented the 5 pathway steps (Q4)
To support all trusts in the implementation of the best practice timed pathway, the SWAG Cancer Alliance have set aside £125,000 (deliverable 1.8) in funds with an aim of compliance with CWT diagnostic standards for Optimised OG Pathway and ensure quality standardisation reducing variability across region.
The project timescales we have for this are:
In Q1 & Q2 Map OG pathway at all trustsAgree IDA pathwayIdentify inefficiencies delaying diagnosis,Agree funding for trust improvements
In Q3 & Q4 Agree best practice in OG pathway managementDeliver trust improvements
OGD Gap Analysis:
We have asked each cancer manager in the Trusts in the SWAG alliance to undertake a GAP analysis audit of their existing OGD pathway.
As this is the first time that we have asked for this to be completed for OGD, we asked for as much information as they have and with their ‘real knowledge’ of their current service – rather than what their pathway defines.
The original deadline of 31st July, for completion and return, was extended to 21st August; to enable all trusts to complete and taking into account summer holiday/annual leave pressures.
These are to be to collated and reviewed to enable to SWAG cancer alliance to look at how we can best support all trusts in the implementation of the best practice timed pathway.
